Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 1/20 | 0.64 |
| ▸ | ACP3 | P15309 | 1/20 | 0.55 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | LTA4H | P09960 | 2/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MITF | O75030 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | MMP13 | P45452 | 1/20 | 0.47 |
| ▸ | MIF | P14174 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL358549 | 0.94 | CYP17A1 (0.70) | CYP17A1ACP3CA4ALDH1A1MAPT | |
| Benzylamine SCHEMBL9396009 | 0.86 | ALDH1A1 (0.55) | CYP17A1ALDH1A1LTA4HCNR2KMT2A | |
| SCHEMBL11756610 | 0.85 | KMT2A (0.61) | CYP17A1ACP3CA4ALDH1A1KMT2A | |
| SCHEMBL12506256 | 0.84 | HTR2A (0.56) | LMNATDP1MIF | |
| SCHEMBL24610441 | 0.84 | CYP17A1 (0.60) | CYP17A1LTA4HKMT2ALMNAMAPT | |
| SCHEMBL8081733 | 0.84 | CYP17A1 (0.60) | CYP17A1LTA4HCNR1CNR2MITF | |
| SCHEMBL29277734 | 0.82 | GPR88 (0.52) | CYP17A1ACP3PBRM1CA4ALDH1A1 | |
| SCHEMBL29277735 | 0.82 | GPR88 (0.52) | CYP17A1ACP3PBRM1CA4ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL5999968 | 0.82 | CYP17A1 (0.61) | CYP17A1ALDH1A1KMT2A | |
| Ammonia Solution, Strong SCHEMBL6000897 | 0.82 | CYP17A1 (0.50) | CYP17A1ALDH1A1CNR1CNR2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4215567-A1 | AQUEOUS BINDER COMPOSITION | ROCKWOOL A/S (DK) | 2023-07-26 | — | — | EP | disclosed |
| US-20090099214-A1 | Organic Compounds | NOVARTIS AG | 2009-04-16 | — | — | US | disclosed |
| US-20090099214-A1 | Organic Compounds | NOVARTIS AG | 2009-04-16 | — | — | US | disclosed |
| WO-2007121919-A1 | PURINE DERIVATIVES WITH ACTIVITY TO THE ADENOSINE A2A RECEPTOR | NOVARTIS AG (CH) | 2007-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099214-A1 | Organic Compounds | CYP3A43, OXER1, OPRM1 | CYP17A1 131/4885ACP3 2676/4885PBRM1 440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.